financetom
Business
financetom
/
Business
/
Amphenol Insider Sold Shares Worth $21,469,140, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Amphenol Insider Sold Shares Worth $21,469,140, According to a Recent SEC Filing
Nov 9, 2024 12:41 PM

04:48 PM EST, 11/07/2024 (MT Newswires) -- Craig A Lampo, Senior Vice President & CFO, on November 06, 2024, sold 300,000 shares in Amphenol ( APH ) for $21,469,140. Following the Form 4 filing with the SEC, Lampo has control over a total of 458,000 shares of the company, with 318,116 shares held directly and 139,884 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/820313/000110465924115286/xslF345X05/tm2427794-1_4seq1.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tencent Music beats quarterly revenue estimates (March 19)
Tencent Music beats quarterly revenue estimates (March 19)
Mar 20, 2024
HONG KONG, March 19 (Reuters) - China's Tencent Music Entertainment Group ( TME ) beat fourth-quarter revenue estimates on Tuesday, driven by growth in paid subscription on its Spotify ( SPOT )-like music streaming platform. The audio entertainment platform reported revenue of 6.89 billion yuan ($957.06 million) for the quarter, marking a 7.2% decline as compared to the same period...
General Mills posts smaller-than-expected drop in quarterly sales
General Mills posts smaller-than-expected drop in quarterly sales
Mar 20, 2024
March 20 (Reuters) - Cheerios maker General Mills ( GIS ) posted a smaller-than-expected drop in quarterly sales on Wednesday, backed by higher prices for its breakfast cereals, snack bars and pet food products that helped cushion a blow from slowing demand. The Cheerios cereal maker's net sales dropped about 1% to $5.1 billion in the third quarter, compared with...
Bristol Myers liver cancer treatment meets main goal of late-stage study
Bristol Myers liver cancer treatment meets main goal of late-stage study
Mar 20, 2024
March 20 (Reuters) - Bristol Myers Squibb ( BMY ) said on Wednesday a combination of its drugs, Opdivo and Yervoy, met the main goal of a late-stage study evaluating it as a first-line treatment for a type of liver cancer. (Reporting by Puyaan Singh) ...
BioNTech Q4 Earnings, Revenue Fall; Sets 2024 Revenue Guidance -- Shares Drop Premarket
BioNTech Q4 Earnings, Revenue Fall; Sets 2024 Revenue Guidance -- Shares Drop Premarket
Mar 20, 2024
07:01 AM EDT, 03/20/2024 (MT Newswires) -- BioNTech (BNTX) reported Q4 earnings Wednesday of 1.90 euro ($2.06) per diluted share, down from 9.26 euros a year earlier. Analysts polled by Capital IQ expected 2.65 euros. Revenue for the quarter ended Dec. 31 was 1.48 billion euros, down from 4.28 billion euros a year earlier. Analysts surveyed by Capital IQ expected...
Copyright 2023-2026 - www.financetom.com All Rights Reserved